Patents by Inventor Courtney Houchen

Courtney Houchen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230310407
    Abstract: Provided are methods useful for preventing and mitigating radiation injury, including acute radiation syndrome, comprising administering to a subject a therapeutically effective amount of a compound represented by formula I or a pharmaceutically acceptable salt thereof, wherein Z is —O— or —N(H)—.
    Type: Application
    Filed: June 8, 2023
    Publication date: October 5, 2023
    Inventors: Milton L. Brown, Yali Kong, Courtney Houchen, Sripathi M. Sureban, Parthasarathy Chandrakesan
  • Patent number: 11672789
    Abstract: Provided are methods useful for preventing and mitigating radiation injury, including acute radiation syndrome, comprising administering to a subject a therapeutically effective amount of a compound represented by formula I or a pharmaceutically acceptable salt thereof, wherein Z is —O— or —N(H)—.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: June 13, 2023
    Assignees: Georgetown University, The Board of Regents of the University of Oklahoma
    Inventors: Milton L. Brown, Yali Kong, Courtney Houchen, Sripathi M. Sureban, Parthasarathy Chandrakesan
  • Publication number: 20230033749
    Abstract: Provided are methods useful for preventing and mitigating radiation injury, including acute radiation syndrome, comprising administering to a subject a therapeutically effective amount of a compound represented by formula I or a pharmaceutically acceptable salt thereof, wherein Z is —O— or —N(H)—.
    Type: Application
    Filed: April 25, 2022
    Publication date: February 2, 2023
    Inventors: Milton L. Brown, Yali Kong, Courtney Houchen, Sripathi M. Sureban, Parthasarathy Chandrakesan
  • Patent number: 11311526
    Abstract: Provided are methods useful for preventing and mitigating radiation injury, including acute radiation syndrome, comprising administering to a subject a therapeutically effective amount of a compound represented by formula I: or a pharmaceutically acceptable salt thereof, wherein Z is —O— or —N(H)—.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: April 26, 2022
    Assignees: Georgetown University, The Board of Regents of the University of Oklahoma
    Inventors: Milton L. Brown, Yali Kong, Courtney Houchen, Sripathi M. Sureban, Parthasarathy Chandrakesan
  • Publication number: 20200306234
    Abstract: Provided are methods useful for preventing and mitigating radiation injury, including acute radiation syndrome, comprising administering to a subject a therapeutically effective amount of a compound represented by formula I: or a pharmaceutically acceptable salt thereof, wherein Z is —O—or —N(H)—.
    Type: Application
    Filed: March 31, 2017
    Publication date: October 1, 2020
    Inventors: Milton L. Brown, Yali Kong, Courtney Houchen, Sripathi M. Sureban, Parthasarathy Chandrakesan
  • Patent number: 9663585
    Abstract: Monoclonal antibodies against DCLK1 and conjugates containing these monoclonal antibodies are disclosed. Methods of producing and using these monoclonal antibodies are also disclosed.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: May 30, 2017
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Courtney Houchen, Sripathi M. Sureban, Randal May, Dongfeng Qu, Nathaniel Weygant
  • Patent number: 8936941
    Abstract: DCAMKL-1 has been identified as a biomarker for stem cells, as well as cancer stem cells. Methods of detecting the presence of at least one stem cell, methods of isolating stem cells, and methods of inhibiting growth of cancer cells utilizing DCAMKL-1 are disclosed herein.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: January 20, 2015
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Shrikant Anant, Courtney Houchen, Satish Ramalingam, Rama Ramanujam, Dharmalingam Subramanlam
  • Publication number: 20140056972
    Abstract: Monoclonal antibodies against DCLK1 and conjugates containing these monoclonal antibodies are disclosed. Methods of producing and using these monoclonal antibodies are also disclosed.
    Type: Application
    Filed: November 6, 2013
    Publication date: February 27, 2014
    Applicant: The Board of Regents of the University of Oklahoma
    Inventors: Courtney Houchen, Sripathi M. Sureban, Randal May, Dongfeng Qu, Nathaniel Weygant
  • Patent number: 8198255
    Abstract: DCAMKL-1 has been identified as a biomarker for stem cells, as well as cancer stem cells. Methods of detecting the presence of at least one stem cell, methods of isolating stem cells, and methods of inhibiting growth of cancer cells utilizing DCAMKL-1 are disclosed herein.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: June 12, 2012
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Courtney Houchen, Randal May, Shrikant Anant, Sripathi M. Sureban
  • Publication number: 20110283372
    Abstract: DCAMKL-1 has been identified as a biomarker for stem cells, as well as cancer stem cells. Methods of detecting the presence of at least one stem cell, methods of isolating stem cells, and methods of inhibiting growth of cancer cells utilizing DCAMKL-1 are disclosed herein.
    Type: Application
    Filed: February 15, 2011
    Publication date: November 17, 2011
    Inventors: Shrikant Anant, Courtney Houchen, Satish Ramalingam, Rama Ramanujam, Dharmalingam Subramanlam
  • Patent number: 7956044
    Abstract: Compositions for inhibiting RNA binding proteins, as well as methods of producing and using same, are disclosed herein.
    Type: Grant
    Filed: April 3, 2009
    Date of Patent: June 7, 2011
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Courtney Houchen, Shrikant Anant, Sripathi M. Sureban
  • Patent number: 7902166
    Abstract: Compositions for inhibiting RNA binding proteins, as well as methods of producing and using the same, are disclosed herein.
    Type: Grant
    Filed: April 20, 2009
    Date of Patent: March 8, 2011
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Courtney Houchen, Shrikant Anant, Sripathi M. Sureban, Satish Ramalingam, Dhamalingam Surbramaniam, Rama P. Ramanujam
  • Publication number: 20090285883
    Abstract: DCAMKL-1 has been identified as a biomarker for stem cells, as well as cancer stem cells. Methods of detecting the presence of at least one stem cell, methods of isolating stem cells, and methods of inhibiting growth of cancer cells utilizing DCAMKL-1 are disclosed herein.
    Type: Application
    Filed: May 15, 2009
    Publication date: November 19, 2009
    Inventors: Courtney Houchen, Randal May, Shrikant Anant, Sripathi M. Sureban
  • Publication number: 20090252784
    Abstract: Compositions for inhibiting RNA binding proteins, as well as methods of producing and using the same, are disclosed herein.
    Type: Application
    Filed: April 20, 2009
    Publication date: October 8, 2009
    Inventors: Courtney Houchen, Shrikant Anant, Sripathi M. Sureban, Satish Ramalingam, Dhamalingam Surbramaniam, Rama P. Ramanujam